Asthma Study CIGE025A2432 Clinical Trial Information

Novartis Clinical Trials and Medical Research Studies Recruiting in the U.S.

Mailing List


	Sign up and receive information about Novartis clinical trials in your health-related areas of interest. For U.S. residents only.

Novartis Clinical Trials provides information about research studies recruiting within the U.S. Visit ClinicalTrials.gov, a registry of federally and privately supported clinical trial for more information regarding clinical trials outside of the U.S.

Study Description

Screening

Study Centers

Contact/Consent

Asthma Study CIGE025A2432

The purpose of this clinical trial is to find out if the drug omalizumab (Xolair®) has beneficial effects on the airways in people who have moderate to severe allergic asthma. Xolair® has been approved in the European Union and by the U.S Food and Drug Administration for the treatment of persistent allergic asthma.
Trial phase: Phase 4
Participation Duration: Participation in the study will last approximately one and a half years. During that time, participants will be asked to visit the study center to receive subcutaneous (under the skin) injections of study medication and assessments.
Protocol Number: CIGE025A2432

The next step is to see if you (or the participant) meet the basic criteria required for participation in this clinical trial. Please fill out the questionnaire below to see if you (or the participant) may be suitable for the clinical trial. Your answers to these questions are not retained by this system. You must answer the questions below for yourself, or, you must be the legally authorized representative of the potential participant in order to answer the questions on their behalf. If you (or the participant) do not meet the preliminary qualifications, you may search for other clinical trials of interest or sign up to the Mailing List.

Answers to all questions are required to determine if you meet the preliminary qualifications for the study.

1) Participation in a clinical trial will require travel to a study center where the clinical trial is being conducted. How far would you (or the participant) be willing to travel to a study center to participate in this clinical trial? Please note that participation in these clinical trials may require a number of visits to the study center and travel expenses may not be covered.

25 miles 50 miles 100 miles 150 miles Unlimited

2) Please enter your residential postal zip code.

3) Are you between 18 and 60 years of age?
Yes
No

4) Have you been diagnosed with moderate to severe allergic asthma that requires an inhaler to control your asthma symptoms?
Yes
No

5) Are you a current smoker?
Yes
No

6) On average, do you now or did you ever smoke about one pack of cigarettes per day (or more) for 10 years or longer?
Yes
No
Never been a smoker

7) Do you have or have you ever had any type of cancer?
Yes
No

8) Have you been diagnosed with either emphysema or chronic bronchitis or COPD?
Yes
No

9) Have you been treated for substance abuse (drugs or alcohol) in the past year?
Yes
No

10) Are you able to successfully perform spirometry measurements?
Yes
No

11) If female, are you pregnant or nursing?
Yes
No
Male

	Site Map \| Contact Us \| Find a Clinical Trial \| Mailing List \| Clinical Trial FAQs
	Clinical Trials Glossary \| About Informed Consent \| Medical Research Areas
	Clinical Trial Resources \| How to use this website